Benzinga | Nov 15, 2021 10:52AM EST

Jefferies Initiates Coverage On Ventyx Biosciences with Buy Rating, Announces Price Target of $30

Jefferies analyst Michael Yee initiates coverage on Ventyx Biosciences (NASDAQ:VTYX) with a Buy rating and announces Price Target of $30.